Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? (Q38090585)

28 August 2017

Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

28 August 2017

0 references

0 references

1 reference

1 reference

Ryan M Kwok

1

1 reference

28 August 2017

Dawn M Torres

series ordinal

2

1 reference

28 August 2017

Stephen A Harrison

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

29 July 2013

1 reference

28 August 2017

1 reference

28 August 2017

58

1 reference

28 August 2017

1166-1174

1 reference

28 August 2017

3

1 reference

Regulation of vitamin D metabolism

28 August 2017

1 reference

"Activation" of vitamin D by the liver

21 January 2018

1 reference

21 January 2018

Vitamin D: metabolism

1 reference

Heritability and environmental factors affecting vitamin D status in rural Chinese adolescent twins

21 January 2018

1 reference

Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects

21 January 2018

1 reference

CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans

21 January 2018

1 reference

Vitamin D and the vitamin D receptor in liver pathophysiology

21 January 2018

1 reference

Nonclassic actions of vitamin D

21 January 2018

1 reference

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts

21 January 2018

1 reference

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages

21 January 2018

1 reference

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

21 January 2018

1 reference

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

21 January 2018

1 reference

Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.

21 January 2018

1 reference

Vitamin D controls T cell antigen receptor signaling and activation of human T cells

21 January 2018

1 reference

Vitamin D and type 2 diabetes: a systematic review

21 January 2018

1 reference

Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets.

21 January 2018

1 reference

Identification of a Vitamin D response element in the human insulin receptor gene promoter

21 January 2018

1 reference

Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3).

21 January 2018

1 reference

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

21 January 2018

1 reference

1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes

21 January 2018

1 reference

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Serum vitamin D concentrations and unexplained elevation in ALT among US adults

21 January 2018

1 reference

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes

21 January 2018

1 reference

Human fatty liver disease: old questions and new insights

21 January 2018

1 reference

Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis

21 January 2018

1 reference

Adipose tissue, adipokines, and inflammation

21 January 2018

1 reference

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

Pioglitazone in the treatment of NASH: the role of adiponectin

21 January 2018

1 reference

Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies

21 January 2018

1 reference

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

Obesity-associated improvements in metabolic profile through expansion of adipose tissue

21 January 2018

1 reference

Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance

21 January 2018

1 reference

The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS.

21 January 2018

1 reference

Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population

21 January 2018

1 reference

The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance.

21 January 2018

1 reference

Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets

21 January 2018

1 reference

Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy

21 January 2018

1 reference

Resistin up-regulates COX-2 expression via TAK1-IKK-NF-kappaB signaling pathway

21 January 2018

1 reference

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression.

21 January 2018

1 reference

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

FXR signaling in the enterohepatic system

21 January 2018

1 reference

1alpha,25-Dihydroxyvitamin D(3) triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo.

21 January 2018

1 reference

Features, diagnosis, and treatment of nonalcoholic fatty liver disease

21 January 2018

1 reference

Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.

21 January 2018

1 reference

Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2.

21 January 2018

1 reference

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

21 January 2018

1 reference

Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis

21 January 2018

1 reference

Clinical practice. Vitamin D insufficiency

21 January 2018

1 reference

Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance

21 January 2018

1 reference

A genome-wide linkage scan for 25-OH-D(3) and 1,25-(OH)2-D3 serum levels in asthma families

21 January 2018

1 reference

7 January 2021

Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor

1 reference

7 January 2021

Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial

1 reference

7 January 2021

Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease

1 reference

7 January 2021

Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice

1 reference

7 January 2021

Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation

1 reference

7 January 2021

Energy intake is associated with endotoxemia in apparently healthy men.

1 reference

7 January 2021

Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats

1 reference

7 January 2021

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26390

1 reference

28 August 2017

1 reference